Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Jim Cramer - Mad Money
Laboratory Corp. of American HoldingsLHDON'T BUYDec 12, 2022
They did very well during Covid, but that's it.
Jim Cramer - Mad MoneyUnknown
N/A
Stock price when the opinion was issued
$265.27
As of Jun 11, 2026. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
TOP PICK
Clinical research and testing for drug companies. They have really good visibility of growth ahead of it. (Analysts’ target: $155.00).
Andy NasrOwned
biotechnologypharmaceutical
TOP PICK
Clinical labs. 2 big players own most of the market. Expects volume will increase because of aging population needing more and more tests. Very profitable.
Brad WillockOwned
biotechnologypharmaceutical
TOP PICK
Clinical testing lab. About 40% of US tests by doctors go to either this or Quest Diagnostics (DGX-N). With an aging population, there is more testing giving more revenue. Very predictable, high cash flow driven model.
Brad WillockOwned
biotechnologypharmaceutical
